286 related articles for article (PubMed ID: 33783695)
1. Imaging of neuroendocrine tumors: A pictorial review of the clinical value of different imaging modalities.
Pirasteh A; Lovrec P; Bodei L
Rev Endocr Metab Disord; 2021 Sep; 22(3):539-552. PubMed ID: 33783695
[TBL] [Abstract][Full Text] [Related]
2. Imaging of Neuroendocrine Tumors: Indications, Interpretations, Limits, and Pitfalls.
Yu R; Wachsman A
Endocrinol Metab Clin North Am; 2017 Sep; 46(3):795-814. PubMed ID: 28760239
[TBL] [Abstract][Full Text] [Related]
3. The radionuclide molecular imaging and therapy of neuroendocrine tumors.
Li S; Beheshti M
Curr Cancer Drug Targets; 2005 Mar; 5(2):139-48. PubMed ID: 15810878
[TBL] [Abstract][Full Text] [Related]
4. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.
Ambrosini V; Kunikowska J; Baudin E; Bodei L; Bouvier C; Capdevila J; Cremonesi M; de Herder WW; Dromain C; Falconi M; Fani M; Fanti S; Hicks RJ; Kabasakal L; Kaltsas G; Lewington V; Minozzi S; Cinquini M; Öberg K; Oyen WJG; O'Toole D; Pavel M; Ruszniewski P; Scarpa A; Strosberg J; Sundin A; Taïeb D; Virgolini I; Wild D; Herrmann K; Yao J
Eur J Cancer; 2021 Mar; 146():56-73. PubMed ID: 33588146
[TBL] [Abstract][Full Text] [Related]
5. Imaging neuroendocrine tumors: Characterizing the spectrum of radiographic findings.
Baghdadi A; Ghadimi M; Mirpour S; Hazhirkarzar B; Motaghi M; Pawlik TM; Kamel IR
Surg Oncol; 2021 Jun; 37():101529. PubMed ID: 33549952
[TBL] [Abstract][Full Text] [Related]
6. Octreoscan Versus FDG-PET for Neuroendocrine Tumor Staging: A Biological Approach.
Squires MH; Volkan Adsay N; Schuster DM; Russell MC; Cardona K; Delman KA; Winer JH; Altinel D; Sarmiento JM; El-Rayes B; Hawk N; Staley CA; Maithel SK; Kooby DA
Ann Surg Oncol; 2015 Jul; 22(7):2295-301. PubMed ID: 25786743
[TBL] [Abstract][Full Text] [Related]
7. Nuclear medicine techniques for the imaging and treatment of neuroendocrine tumours.
Teunissen JJ; Kwekkeboom DJ; Valkema R; Krenning EP
Endocr Relat Cancer; 2011 Oct; 18 Suppl 1():S27-51. PubMed ID: 22005114
[TBL] [Abstract][Full Text] [Related]
8. Current status and future prospects of PET-imaging applications in patients with gastro-entero-pancreatic neuroendocrine tumors (GEP-NETs).
Papadakis GZ; Karantanas AH; Marias K; Millo C
Eur J Radiol; 2021 Oct; 143():109932. PubMed ID: 34482177
[TBL] [Abstract][Full Text] [Related]
9. Anatomic and Functional Imaging of Neuroendocrine Tumors.
Morse B; Al-Toubah T; Montilla-Soler J
Curr Treat Options Oncol; 2020 Jul; 21(9):75. PubMed ID: 32728967
[TBL] [Abstract][Full Text] [Related]
10. 68Ga-DOTATATE PET/MRI for Neuroendocrine Tumors: A Pictorial Review.
Nguyen NC; Moon CH; Muthukrishnan A; Furlan A
Clin Nucl Med; 2020 Sep; 45(9):e406-e410. PubMed ID: 32520493
[TBL] [Abstract][Full Text] [Related]
11. Imaging neuroendocrine tumours with radionuclide techniques.
Gnanasegaran G; O'Doherty MJ
Minerva Endocrinol; 2008 Jun; 33(2):105-26. PubMed ID: 18425057
[TBL] [Abstract][Full Text] [Related]
12. MIB-1 Index-Stratified Assessment of Dual-Tracer PET/CT with
Sampathirao N; Basu S
J Nucl Med Technol; 2017 Mar; 45(1):34-41. PubMed ID: 28154019
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a Neurokinin-1 Receptor-Targeted Technetium-99m Conjugate for Neuroendocrine Cancer Imaging.
Kanduluru AK; Srinivasarao M; Wayua C; Low PS
Mol Imaging Biol; 2020 Apr; 22(2):377-383. PubMed ID: 31292915
[TBL] [Abstract][Full Text] [Related]
14. Current Practices and Novel Techniques in the Diagnosis and Management of Neuroendocrine Tumors of Unknown Primary.
Hendifar AE; Ramirez RA; Anthony LB; Liu E
Pancreas; 2019 Oct; 48(9):1111-1118. PubMed ID: 31609931
[TBL] [Abstract][Full Text] [Related]
15. Functional Imaging in the Follow-Up of Enteropancreatic Neuroendocrine Tumors: Clinical Usefulness and Indications.
Merola E; Pavel ME; Panzuto F; Capurso G; Cicchese N; Rinke A; Gress TM; Iannicelli E; Prosperi D; Pizzichini P; Prasad V; Kump P; Lipp R; Partelli S; Falconi M; Wiedenmann B; Delle Fave G
J Clin Endocrinol Metab; 2017 May; 102(5):1486-1494. PubMed ID: 28324047
[TBL] [Abstract][Full Text] [Related]
16. [Gastroenteropancreatic endocrine tumors].
Schmid-Tannwald C; Schmid-Tannwald CM; Reiser MF; Berger F
Radiologe; 2014 Oct; 54(10):989-97. PubMed ID: 25234769
[TBL] [Abstract][Full Text] [Related]
17. The role of 68Ga-DOTA-NOC PET/CT in evaluating neuroendocrine tumors: real-world experience from two large neuroendocrine tumor centers.
Haidar M; Shamseddine A; Panagiotidis E; Jreige M; Mukherji D; Assi R; Abousaid R; Ibrahim T; Haddad MM; Vinjamuri S
Nucl Med Commun; 2017 Feb; 38(2):170-177. PubMed ID: 27922538
[TBL] [Abstract][Full Text] [Related]
18. Neuroendocrine Tumors: Imaging of Treatment and Follow-up.
Migut AE; Kaur H; Avritscher R
Radiol Clin North Am; 2020 Nov; 58(6):1161-1171. PubMed ID: 33040855
[TBL] [Abstract][Full Text] [Related]
19. Nuclear imaging of neuroendocrine tumours.
Sundin A; Garske U; Orlefors H
Best Pract Res Clin Endocrinol Metab; 2007 Mar; 21(1):69-85. PubMed ID: 17382266
[TBL] [Abstract][Full Text] [Related]
20. Update on nuclear medicine imaging of neuroendocrine tumors.
Goldsmith SJ
Future Oncol; 2009 Feb; 5(1):75-84. PubMed ID: 19243300
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
